Hinge Bio
Dr. Hershberg has more than 40 years of experience in biotechnology in the areas of recovery process development and large-scale manufacturing operations. He worked at Hoffmann LaRoche, Genentech, Immunex, and Amgen and has consulted for developing and major pharmaceutical companies. Dr. Hershberg had a major role in the development of ten commercial products encompassing cytokines, hormones, vaccines, blood factors, and antibodies. In addition, he worked in Pharmaceutical Sciences and contributed to the development of formulations for several commercial products. Dr. Hershberg received his Ph.D. from University of Pennsylvania in Biochemistry and a B.S. in chemistry from University of Pittsburgh.
This person is not in any offices
Hinge Bio
Hinge Bio, Inc. is a privately-held biotechnology company leveraging its powerful GEM-DIMER™ platform to develop therapeutics that address the problems of inadequate efficacy and resistance in infectious disease and oncology.